TrademarkOpen
Search / US trademark / 79441998
US service mark

ECHO

Registered

Status timeline

  1. 22 Jan 2026
    Application received from the International Bureau (Madrid)
    Sn Assigned For Sect 66a Appl From Ib
  2. 6 Mar 2026
    Assigned to an examining attorney
    Assigned To Examiner
  3. 27 Mar 2026
    Office action issued
    Non-Final Action Written
  4. 9 Jun 2026
    Response to office action filed
    Teas Response To Office Action Received
  5. 13 Jun 2026
    Approved for publication
    Approved For Pub - Principal Register
  6. 14 Jul 2026
    Published for opposition
    Published For Opposition
  7. 1 Sep 2026
    Registered on the Principal Register
    Registered-Principal Register
All 20 USPTO events
2026-09-01Registered-Principal Register
2026-07-14Published For Opposition
2026-07-14Official Gazette Publication Confirmation E-Mailed
2026-07-09Notification Processed By Ib
2026-07-08Notification Of Notice Of Publication E-Mailed
2026-06-24Notice Of Start Of Opposition Period Created, To Be Sent To Ib
2026-06-24Notification Of Possible Opposition Sent To Ib
2026-06-13Approved For Pub - Principal Register
2026-06-09Teas Response To Office Action Received
2026-06-09Correspondence Received In Law Office
2026-06-09Teas/Email Correspondence Entered
2026-06-04Refusal Processed By Ib
2026-05-15Non-Final Action Mailed - Refusal Sent To Ib
2026-05-14Refusal Processed By Mpu
2026-03-28Non-Final Action (Ib Refusal) Prepared For Review
2026-03-27Non-Final Action Written
2026-03-06Assigned To Examiner
2026-01-27New Application Office Supplied Data Entered
2026-01-27Application Filing Receipt Mailed
2026-01-22Sn Assigned For Sect 66a Appl From Ib

Goods & services

Class 40 Materials treatment

Custom biomanufacture of therapeutic iPSC-based cells, iPSC-based cells for use in cell therapies and iPSC-based allogeneic edited cells for use in therapies, for others; custom biomanufacture of iPSC-based allogeneic cells for use in cell therapies

Class 42 Technology & SaaS

Scientific research, design and technological development services in the fields of scientific iPSC-based cell cultures, iPSC-based cell therapies, and iPSC-based gene-edited cell therapy; scientific research, design and development of manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific research consultation services in the field of biotechnology, specifically in relation to iPSC-based cell culture, iPSC-based cell therapy, or iPSC-based gene edited cell therapy manufacturing

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 31 Aug 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.